![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Excedrin_Migraine.jpg/640px-Excedrin_Migraine.jpg&w=640&q=50)
Excedrin (brand)
Over-the-counter headache pain reliever / From Wikipedia, the free encyclopedia
Excedrin is an over-the-counter headache pain reliever, typically in the form of tablets or caplets. It contains paracetamol (acetaminophen), aspirin, and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other products from BMS's over-the-counter business. As of March 2015, GSK holds majority ownership of Excedrin through a joint venture transaction with Novartis.[1] On 18 July 2022, GSK spun off its consumer healthcare business (including Excedrin) to Haleon.
![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
![](http://upload.wikimedia.org/wikipedia/commons/thumb/c/c0/Excedrin_Migraine.jpg/640px-Excedrin_Migraine.jpg)
The brand became known for advertisements where it cured especially unpleasant and excruciating headaches (called "Excedrin headaches" in the ads of 1970s,[2] and later called "Excedrin tension headaches"). In 2007, the brand branched out into marketing for other types of pains with the introduction of Excedrin Back & Body, without caffeine.